Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early – MarketWatch

Guardant Health IPO: 5 things to know about the startup that wants to detect cancer early
MarketWatch
That’s the premise of the buzzy cancer-testing startup Guardant Health, which plans to go public in the coming weeks and trade on Nasdaq under the ticker “GH.” The company expects to offer 12.5 million common shares at between $15 and $17 per share, …

…read more

Source:: Startup Tech News From Google News

Leave a Comment